Your browser doesn't support javascript.
loading
Mass Cytometry Reveals Classical Monocytes, NK Cells, and ICOS+ CD4+ T Cells Associated with Pembrolizumab Efficacy in Patients with Lung Cancer.
Rochigneux, Philippe; Lisberg, Aaron; Garcia, Alejandro; Granjeaud, Samuel; Madroszyk, Anne; Fattori, Stéphane; Gonçalves, Anthony; Devillier, Raynier; Maby, Pauline; Salem, Nassim; Gorvel, Laurent; Chanez, Brice; Gukasyan, Jaklin; Carroll, James; Goldman, Jonathan; Chretien, Anne Sophie; Olive, Daniel; Garon, Edward B.
Afiliación
  • Rochigneux P; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles, California.
  • Lisberg A; Department of Medical Oncology, Paoli-Calmettes Institute, Marseille, France.
  • Garcia A; Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille University UM105 and Paoli-Calmettes Institute, Marseille, France.
  • Granjeaud S; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles, California.
  • Madroszyk A; Cytometry Core Laboratory, David Geffen School of Medicine at the University of California, Los Angeles, California.
  • Fattori S; Integrative Bioinformatics Platform, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR 7258, Aix-Marseille University UM105 and Paoli-Calmettes Institute, Marseille, France.
  • Gonçalves A; Department of Medical Oncology, Paoli-Calmettes Institute, Marseille, France.
  • Devillier R; Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille University UM105 and Paoli-Calmettes Institute, Marseille, France.
  • Maby P; Department of Medical Oncology, Paoli-Calmettes Institute, Marseille, France.
  • Salem N; Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille University UM105 and Paoli-Calmettes Institute, Marseille, France.
  • Gorvel L; Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille University UM105 and Paoli-Calmettes Institute, Marseille, France.
  • Chanez B; Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille University UM105 and Paoli-Calmettes Institute, Marseille, France.
  • Gukasyan J; Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille University UM105 and Paoli-Calmettes Institute, Marseille, France.
  • Carroll J; Department of Medical Oncology, Paoli-Calmettes Institute, Marseille, France.
  • Goldman J; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles, California.
  • Chretien AS; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles, California.
  • Olive D; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles, California.
  • Garon EB; Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille University UM105 and Paoli-Calmettes Institute, Marseille, France.
Clin Cancer Res ; 28(23): 5136-5148, 2022 12 01.
Article en En | MEDLINE | ID: mdl-36166003

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos